| Page 54 | Cafepharma

You are here

Primary tabs

Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica

Post date: June 6, 2018 - 9:17am

BioCryst Urges Stockholders To Vote For Merger With Idera

Post date: June 5, 2018 - 9:51am

Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis

Post date: June 5, 2018 - 9:24am

EATRIS Announces Novel Public-Private Collaboration for Imaging Method Development in Inflammatory Diseases

Post date: June 4, 2018 - 11:15am

More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer

Post date: June 4, 2018 - 9:12am

Encorafenib and Binimetinib Combination Results Show Improved Survival in Braf-Mutant Advanced Melanoma Patient

Post date: June 4, 2018 - 8:54am

Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

Post date: June 1, 2018 - 9:56am

Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors

Post date: June 1, 2018 - 9:37am

Siolta Therapeutics and CoreBiome – a Look at Two Different Ways Biotech is Developing Microbiome Related Products

Post date: May 31, 2018 - 9:59am

vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor

Post date: May 31, 2018 - 9:28am

Pages